Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications ...

Group psychedelic -therapy protocols are estimated to lower clinician costs by 34.7%, or $981 per patient, for psilocybin-based care. Recent modeling.